PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Various flavonoids and steroidal saponins demonstrated cytotoxic activities against human cancer cell lines including K-562, SMMC-7721, and SGC-7901 [PMID:21800280, PMID:24480383, PMID:19219735]
Compounds exhibited antibacterial activities against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA) [PMID:21800280, PMID:25523446], as well as Fusarium oxysporum and Ralstonia solanacearum [PMID:27062817]
Ethyl acetate fractions showed DPPH, ABTS+, and Superoxide anion radical-scavenging capacities, suggesting use as natural antioxidants [PMID:21135802]
Evidence summary
PubMed sources
- 1.PMID: 28648631 (2017) — Flavonoids from artificially induced dragon's blood of Dracaena cambodiana. · Fitoterapia
- 2.PMID: 24480383 (2014) — Steroidal saponins from dragon's blood of Dracaena cambodiana. · Fitoterapia
- 3.PMID: 39138230 (2024) — Chromosome-level and haplotype-resolved genome assembly of Dracaena cambodiana (Asparagaceae). · Scientific data
- 4.PMID: 36919819 (2023) — Structure and histochemistry of the stem of Dracaena cambodiana Pierre ex Gagnep. · Microscopy research and technique
- 5.PMID: 28597686 (2018) — Three new flavanoids from artificially induced dragon's blood of Dracaena cambodiana. · Journal of Asian natural products research